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ABSTRACT 
 
We report the synthesis and characterization of a series of symmetrical indolenine-based 
squaraine dyes along with the evaluation of their singlet oxygen generation efficiency. The 
photodynamic activity of these new photosensitizers has been evaluated on a human tumor 
fibrosarcoma (HT-1080) cell line. The cytotoxicity increased over time and is induced by the 
photoactivation of bromo (Br-C4) and iodio (I-C4) long carbon chain squaraine dyes and the 
consequent increase in reactive oxygen species (ROS) production (p < 0.001), which leads to 
necrosis 6 h after treatment. Induction of cytochrome c release, DNA damage and up-regulation of 
GPX1, NQO1 and SOD2 mRNA gene expression after PDT were investigated. 
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1. INTRODUCTION 
Photodynamic therapy (PDT) is an emerging non-invasive technique for the treatment of both 
cancer and non-cancerous conditions [1,2]. It involves the systemic or topic administration of a 
photosensitizer (PS) that, after its excitation with light at a specific wavelength, is able to produce 
reactive oxygen species (ROS), causing damage to targeted cancer cells. The most important of 
these oxygen species is widely believed to be singlet oxygen (1O2) [3]. In particular, an ideal PS 
should fulfill specific, clinically relevant requirements: i) sharp, intense absorption in the biological 
tissues’ transparency window (600-900 nm), ii) good solubility in the biological environment, iii) 
low dark toxicity but strong photo-cytotoxicity and a high 1O2 sensitization quantum yield. 
Moreover, an ideal PS should possess a high specificity for cancer tissues and be easily and rapidly 
removed from the body post-treatment [4,5]. 
Several PS have already been proposed and some of them, belonging to the porphyrin family, are 
clinically used [6,7]. However, porphyrins show a number of drawbacks, including relatively poor 
photo-stability, weak absorption above 600 nm, low solubility in water, serious skin 
photosensitization and specific (sometimes undesired) biodistribution. The search for more effective 
PS has therefore become a relevant issue and squaraine dyes deserve to be counted among the 
innovative potential PS classes for photodynamic treatment. 
Squaraines are the products of dicondensation reactions between electron-rich substrates and 
squaric acid. Interest in this old class of organic dyes has been renewed quite recently due to their 
photophysical and photochemical properties, i.e. a high extinction coefficient with an intense 
absorption and fluorescence in the red/near-IR region (between 600 and 850 nm) [8]. These 
properties, along with relative easy tuning syntheses, make squaraine dyes very attractive for their 
use in a large number of fields, such as solar-energy conversion [9], nonlinear optics, biological 
applications [10] and sensitizers for PDT [11]. Indeed, Ramaiah et al. have stated that appropriately 
substituted squaraine dyes can act as novel sensitizers in PDT applications [12] and are interesting 
also for their strong absorption in the tissue transparency window (600-800 nm). They demonstrated 
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that the quantum yield for the photosensitised 1O2 generation of phloroglucinol could be increased 
significantly by halogenating the donor moiety with heavier halogen atoms. Furthermore, 
squaraines are scarcely cytotoxic in the dark, but after irradition, they promote a strong dose-
dependent phototoxic effect in different cancer cells lines [13]. 
In this study, we report the synthesis and characterization of a series of halogenated symmetric 
squaraines which bear chains of different lengths on their nitrogen atoms (Scheme 1). The 
photodynamic activity of these new squaraine based photosensitizers has been evaluated on a 
human fibrosarcoma (HT-1080) cell line by analyzing the effect of photodynamic treatment on cell 
proliferation, cell death, intracellular ROS generation, cytochrome c release, DNA damage and 
mRNA gene expression. 
 
2. RESULTS AND DISCUSSION 
 
2.1 Synthesis 
The classic synthesis of symmetrical squarylium dyes entails the one-pot condensation of electron-
rich aromatic or heterocyclic compounds with squaric acid in a solvent mixture under reflux [14]. 
Barbero et al. have recently proposed an alternative method which makes use of a microwave 
synthesizer [15]. The main advantages of this synthetic approach are decreased reaction times (from 
6-12 h to 20-50 min) and increased squaraine yield and purity. 
This general synthetic procedure starts with the synthesis of the indolenine ring. In this work, the 
starting 5-substituted 2,3,3-trimethylindolium (2a-b) were readily obtained via the condensation of 
benzohydrazine substitute 1a-b with 3-methylbutan-2-one in glacial acetic acid, as previously 
reported [15,16] (see Scheme 2). The subsequent step is the quaternization of the indolenine ring: 
thanks to the nitrogen quaternization, an increase of the acidity of the methyl group will occur 
enabling the bridge formation. Quaternarized salts are previously published compounds and their 
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characterization agrees with literature values. (3a-C2 [17]), (3b-C2 [18]), (3a-bC4 [19,20]). In the 
final step, squaric acid is overheated in a closed vessel under MW radiation with a 2-fold excess of 
the quaternized indolenine in 1-butanol:toluene mixture (1:1, v/v). (Scheme 3, for more details see 
the Experimental section). 
 
2.2 Generation of singlet oxygen 
 A qualitative and comparative study of the abilities of a series of squaraines to generate 
singlet oxygen was carried out by trapping 1O2 with 1,3-diphenylisobenzofuran (DPBF) [21]. In fact 
DPBF reacts rapidly with 1O2 forming the colorless o-dibenzoylbenzene derivative, resulting from 
the disappearance of DPBF's characteristic absorption band at 415 nm. Thus, a solution of DPBF 
(20 µM) and squaraine dyes (5 µM) in PBS pH 7.4 and DMSO (1%) was irradiated in a filtered 
solar box to remove the wavelengths below 515 nm while DPBF consumption was monitored over 
time. The decrease in quencher absorption at 415 nm, as a function of the squaraine irradiation time, 
has been compared to the values obtained from methylene blue (MB), an efficient and well-known 
singlet oxygen generator, proving that all squaraines possess 1O2 generation ability (Figure 1). In 
particular SQ-NH promoted the complete decay of DPBF absorption within 60 min, while the same 
result was obtained in 5-10 min for halogenated SQ. The presence of both bromine and iodine may 
facilitate the singlet to triplet state intersystem crossing that is due to the well-known heavy atom 
effect [12]. 
 
2.3 In vitro photodynamic activity 
2.3.1 Effect of squaraine dye-based photodynamic treatment on HT-1080 cell proliferation 
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 As shown in Figure 2, HT-1080 cells were exposed to varying squaraine dye concentrations 
(from 0.25 to 10 µM) in order to detect the correct non-cytotoxic concentration with which to 
perform photodynamic experiments. A dose-dependent increase in cytotoxicity was observed after 
squaraine dyes incubation. It is clear that the highest squaraine dye concentration (10 µM) is 
already cytotoxic to HT-1080 at 24 hours, and for up to 72 hours, after administration. Lower 
cytotoxicity was observed over time when cells were exposed to a 2 µM squaraine dye 
concentration, specifically with Br-C2, Br-C4 and I-C4. Exposing HT-1080 cells to squaraine dyes, 
from 0.25 to 1 µM and for up to 72 h, did not affect cell viability. All cells were incubated at the 
highest non-toxic concentration tested (1 µM) of squaraine dyes. 
The intracellular uptake of squaraine dyes was also evaluated cytofluorimetrically, as observed in 
Figure 3. Br-NH and I-NH gave significant cellular uptake up to 6 h (p < 0.05) after incubation, 
while SQ-NH uptake remained for up to 24 h (p < 0.05). However, cellular uptake was significantly 
increased over time when squaraine dyes were characterized with two (Br-C2 and I-C2) or four (Br-
C4 and I-C4) carbon chains. Indeed, Br-C4 and I-C4 squaraine dyes already present significant 
intracellular uptake at 3 h (p < 0.05) and for up to 24 h (p < 0.001) after incubation, as can be seen 
in their high iMFI ratio.  
 The photodynamic effects of all the squaraines were observed for up to 72 h after 
photodynamic treatment. The control treatments, i.e., exposure to squaraine derivatives or 
appropriate wavelength light beams alone (LB, 15 mW/cm2 for 20 min) did not affect HT-1080 cell 
proliferation, as seen in Figure 4. Moreover, there was no reduction in cell growth when cells were 
treated with PDT and SQ-NH, Br-NH or I-C2, whereas a slight reduction in cell growth was 
observed with I-NH at 72 h and with Br-C2 at 48 (p < 0.01) and 72 (p <0.001) h after PDT. It is 
worth noting that only when cells were preincubated with Br-C4 or I-C4 it was possible to 
significantly decrease HT-1080 cell proliferation at 24 h ( p < 0.05) and up to 72 h (p < 0.001). 
Thus, it would appear that squaraine dye photodynamic activity may be influenced by the presence 
of long carbon chains in the squaraine dye chemical structure. Indeed, this hypothesis also 
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correlates with the increased iMFI index over time observed in Br-C2, I-C4, Br-C4 and I-C4, as 
compared to the other squaraine dyes (Figure 3). 
 
2.4 Confocal colocalization of Br-C4 and I-C4 in HT-1080 mitochondria 
 It has been suggested that mitochondria are a major subcellular site for photosensitizer 
localization, and that squaraine dyes localize in mitochondria organelles [22]. We therefore decided 
to perform a confocal fluorescent analysis of HT-1080 mitochondria, stained with MitoTracker 
Green, and Br-C4 and I-C4 in order to establish the colocalization. Figure 5 shows that Br-C4 
(panel C) was partially colocalized with the mitochondrial region, while more striking 
colocalization was shown for I-C4 (panel F) and cellular mitochondria, revealing identical overlap 
in the transcellular fluorescence localization profiles. These data appear to strongly suggest that Br-
C4 and I-C4 are held by cellular mitochondria once they penetrate cells. 
 
2.5 Effects of Br-C4 and I-C4 photodynamic treatment on reactive oxygen species production 
 The mechanism of action of most PS has revealed that light irradiation of PS and subsequent 
energy transfer can lead to a series of photochemical reactions, in the presence of O2, and the 
generation of various cytotoxic species (e.g. 1O2 and ROS), which consequently induce cellular 
damage via apoptosis/necrosis [23]. In the present work, 2',7′ dichlorofluorescin diacetate (DCFH-
DA) has been used as a ROS probe to examine photodynamic treatment induced ROS generation. In 
fact, highly fluorescent DCF can be evaluated by flow cytometry at an excitation of 488 nm in the 
presence of peroxides. Intracellular ROS levels were determined 1, 5, 15, 30, 45 and 60 min after 
photodynamic treatment with either LB alone (15mW/cm2 for 20 min) or in combination with either 
Br-C4 or I-C4 (1 µM). Figure 6 shows that combined LB and Br-C4/I-C4 treatment induced a 
significant increase in ROS production 1 min after treatment (p < 0.001), and that this progressively 
decreased over time up to 15 min (p < 0.05). The iMFI ratio was highest when cells were treated 
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with Br-C4 and exposed to PDT; a 30-fold increase was observed 1 min after the treatment (32.00 ± 
4.24). However, the photoexcitation of I-C4 only gave a 15-fold ROS increase (15.32 ± 5.20). In 
vitro ROS production suggested that the presence of both bromine and iodine may facilitate the 
singlet to triplet state intersystem crossing that is due to the well-known heavy atom effect. Our 
results are furthermore in line with Soumya’s work, where an increase in ROS production was 
obtained when Ehrlich’s Ascites Carcinoma (EAC) cells were treated with a symmetrical 
diiodinated benzothiazolium squaraine (SQDI) and then photo-treated [24]. 
 
2.6 Effects of photodynamic treatment with Br-C4 and I-C4 on HT-1080 cell death, cytochrome c 
release and DNA damage 
 The photoactivation of a PS is correlated to events that culminate with apoptosis, leading to 
cell destruction. In particular, it has been reported that the photoactivation of a PS, such as a 
squaraine dye, triggers the apoptotic cell death pathway [25]. Cell proliferation data obtained after 
squaraine dye photoactivation prompted us to focus our attention on Br-C4 and I-C4 squaraine 
dyes, which showed increased activity in cell proliferation reduction (Figure 4). As observed in 
Figure 7A, 80% of the cells that had previously been exposed to Br-C4 (p < 0.001, 81.90 ± 0.14) or 
I-C4 (p < 0.001, 83.00 ± 6.09) were found to be necrotic, by being positive to Annexin V-Alexa 
Fluor® 488 and Propidium Iodide (PI), 6 h after combined treatment with PDT (15 mW/cm2 for 20 
min), while no change in necrotic and apoptotic events was observed when cells were only exposed 
to squaraine dyes or LB alone. Our results are in line with Rapozzi’s work, where squaraine 
photoactivation after HeLa cell line incubation induced an increase in necrotic events [13]. It was 
decided to evaluate the release of cytochrome c in cytosolic extracts of HT-1080 cells that had been 
treated with Br-C4 or I-C4 for 24 h and then exposed to PDT. This is because cytochrome c 
mitochondrial release occurs almost immediately after PDT and is specific to oxidative stress [26]. 
Figure 7B shows a statistically significant and rapid increase, as compared to untreated cells, in the 
9 
	  
release of mitochondrial cytochrome c into cytosol 0.5 h after PDT with both squaraine dyes (p < 
0.001). This is followed by a drastic reduction in release 3 h after the treatment. Despite our data 
being statistically significant, we did not find constant or increased cytosolic cytochrome c release 
over time after photoexposure. These differing cytochrome c release kinetics point to necrosis being 
the principle cell death pathway induced by the photoactivation of squaraine dyes. 
 Although the exact mechanism of damage to the various cellular targets in PDT has been a 
matter of debate in recent years, it has been reported that both Type I and Type II reactions involved 
in PDT can damage cellular constituents (lipids, proteins, DNA) and eventually cause cell death. 
Moreover, it is likely that Br-C4 and I-C4 squaraine dye photodynamic activity affects DNA and so 
we decided to evaluate the treatment's effect on DNA damage. As observed in Figure 7C, PDT with 
either squaraine dye (p < 0.05) caused significant DNA damage. Our results are in line with 
Ramaiah’s work, where  massive damage to DNA was also observed after the photoirradiation of 
Chinese hamster ovary (ASS2) cells that had previously been incubated with halogenated squaraine 
dyes [25]. 
 
2.7 Effect of Br-C4 or I-C4 photodynamic treatment on gene expression 
 In order to profile the changes in gene expression patterns in Br-C4 or I-C4 photodynamic 
induced necrosis and ROS production, total RNA was harvested from HT-1080 0.5, 3 and 24 h after 
PDT with squaraine dyes. Analyzed genes were grouped by function; either as genes involved in the 
induction of apoptosis or the oxidative damage pathway, as shown in Figure 8A and B. 
In agreement with our previous data, both Br-C4 and I-C4 photodynamic activities induced an 
increase in necrosis (Figure 7A). Indeed, there was no significant post-PDT up-regulation in the 
mRNA expression of pro apoptotic (BAX) and Apoptotic Peptidase Activating Factor 1 (APAF1), 
which are involved in programmed cell death. Furthermore, the down-regulation of anti-apoptotic 
BCL-2 mRNA expression was observed over all times considered, although it was not statistically 
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significant (Figure 8A). We observed a significant up-regulation in tumor suppressor TP-53 mRNA 
expression 3 h after PDT activity with Br-C4, but not after I-C4 PDT activity.  
 We investigated the genes involved in ROS production (Figure 8B), and observed a 
significant increase in the expression of GPX1 mRNA, one of the most important antioxidant 
enzymes in the detoxification of hydrogen peroxide, 0.5 h after Br-C4 (p < 0.001) and I-C4 (p < 
0.001) PDT activity and followed its progressive decrease over time. It is important to underline the 
large difference in the expression of GPX1 and that of the other genes analyzed; more than 30- and 
50-fold after PDT with Br-C4 (34.58 ± 5.32) and I-C4 (54.63 ± 5.05), respectively. Figure 8 B 
shows that NQO1, another gene involved in detoxification systems, was significantly up-regulated 
0.5 h after PDT with both Br-C4 (p < 0.05, 3.39 ± 0.50) and I-C4 (p < 0.01, 5.56 ± 0.78). This again 
was followed by a progressive decrease over time, up to 24 h after treatment. We observed a 
significant up-regulation of superoxide dismutase type 2 (SOD2) mRNA gene expression 0.5 h after 
PDT treatment with I-C4 (p < 0.01, 5.21 ± 0.49), but not after Br-C4 PDT. If we consider the gene 
expression pathways that have been studied so far, it is possible to hypothesize that the 
photoactivation of Br-C4 and I-C4 squaraine dyes induces the consistent up-regulation of genes 
involved in the oxidative pathway, such as GPX-1, NOQ1 and SOD2, which itself reflects the 
massive recruitment (induction) of ROS (Figure 6). 
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3. CONCLUSION 
 In conclusion, we have described the synthesis of highly fluorescent near-IR halogenated 
squaraine dyes and their in vitro photoactivation in a human fibrosarcoma (HT-1080) tumor cell 
line. It has been observed that the presence of bromine (Br-C2, Br-C4) or iodine (I-C2, I-C4) 
facilitates the singlet to triplet state intersystem crossing that is due to the well-known heavy atom 
effect. Different in vitro photodynamic activity was observed for each squaraine dye. Specifically, 
only photodynamic treatment with Br-C4 or I-C4 was able to cause significant reductions in cancer 
cell growth. These data also confirm an impressive increase in iMFI ratio. From a SAR (structure-
activity relationship) point of view, this increase may be caused by the presence of a four carbon 
chain that improved cellular uptake probably due to the increase of lipophilicity. It is well known 
that lipophilicity influences the ADMET characteristics of drugs contributing to their solubility and 
permeability through biological membranes. So we can conclude that not only the presence of 
heavy atoms on the squaraine structures will influence the pharmacological activity, but also their 
hydrophilic-lipophilic balance. 
Moreover, the effective intracellular localization of Br-C4 and I-C4 squaraine dyes inside HT-1080 
cells was observed by confocal analysis between squaraine dyes and cellular mitochondria. Br-C4 
and I-C4 photodynamic treatment lead to an increase in ROS production in the very first few 
minutes after treatment. This was then followed by the simultaneous induction of necrotic events  3 
h after treatment and a drastic reduction in cytochrome c. 
In summary, the results described herein suggest that squaraine dyes can be considered promising, 
innovative photosensitizers for use in photodynamic anticancer treatment. The easiness of 
preparation and the possibility to provide a large variety of molecules with different structural 
properties will allow a wide and complete SAR study. 
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4. EXPERIMENTAL 
4.1. Chemistry 
 All solvents and reagents (i.e. (4-bromophenyl)hydrazine, 1a; (4-iodophenyl)hydrazine, 1b; 
2,3,3-trimethyl-3H-indole, 3c) were purchased from commercial sources and used as received 
without further purification, unless otherwise stated. All microwave reactions were performed in a 
single-mode Biotage Initiator 2.5. LC-HRMS analyses were accomplished with an Ultimate 3000 
HPLC instrument (Dionex, Milan, Italy) coupled to an LTQ Orbitrap instrument at a resolution of 
30000 (500 m/z FWHM) in FTMS mode (Thermo Scientific, Rodano, Italy) with an APCI 
interface. 1H NMR spectra were recorded on a Bruker Advance 200 and calibrated to the residual 
solvent peak. All chemical shifts are in ppm and coupling constants are in Hertz (Hz). UV-Vis-NIR 
spectra were recorded on a Shimadzu UV-1700 spectrometer. Spectroscopic grade solvents 
(Chromasolv) from Sigma Aldrich were used for all spectroscopic measurements. 
4.1.1. Synthesis 
 The starting 5-substitute 2,3,3-trimethylindolium (2a-b) was readily obtained via the 
condensation of benzohydrazine substitute 1a-b with 3-methylbutan-2-one in glacial acetic, acid as 
previously reported [15,16] (see Scheme 2). The obtained indolenines were then quaternarized. In a 
typical experiment, an appropriate iodo-alkane (1:4 molar ratio) was placed into a reaction vial with 
CH3CN and 2a-b. The vessel was then sealed with a crimp cap and heated in the microwave system 
at 155°C for 35 min, according to a previously published procedure [15]. The solid formed was 
isolated by filtration and repeatedly washed under stirring with diethyl ether (3 x 200 mL) and then 
filtered, giving pure products 3a-b. 
A suspension of squaric acid (0.5 mmol) and either indolenine or indolium molecules 3 (1 mmol) in 
a 1:1 mixture of butanol:toluene (2 ml) was heated at 160°C in the microwave reactor. The deep 
blue-green mixture was cooled to room temperature and a shiny purple precipitate was formed. The 
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solvent was removed and the precipitate was washed a few times with diethyl ether. Squaraines 
were obtained in 41-82% yields. 
4.1.1.1. 2-[[3-[(1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene)methyl]-2-hydroxy-4-oxo-2-
cyclobuten-1-ylidene]methyl]-3,3-trimethyl-3H-indole (SQ-NH) [27,28]. 
2,3,3-trimethyl-3H-indole (3c) (159.2 mg) and squaric acid (57.0 mg) in butanol/toluene solution 
(1:1, 2 ml) at 160° C for 20 min gave 81 mg of SQ-NH, 0.21 mmol., 41 % yield. 
1H NMR (CD3OD-d4) δ: 7.41-7.24 (m, 8H), 4.87 (s, 2H), 1.31 (s, 12H) 
HRMS (ESI) calcd for C26H24N2O2 [M]+ 397.1838, found 397.1958 
4.1.1.2. 5-bromine-2-[[3-[(1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene)methyl]-2-hydroxy-4-oxo-
2-cyclobuten-1-ylidene]methyl]-5-bromine-3,3-trimethyl-3H-indole (Br-NH) [15]. 
5-bromine-2,3,3-trimethyl-3H-indole (3a) (238.1 mg) and squaric acid (57.0 mg) in butanol/toluene 
solution (1:1, 2 ml) at 160° C for 30 min gave 183 mg of Br-NH, 0.33mmol, 66 % yield. 
1H NMR (CDCl3-d1) δ: 7.44 (4H, m), 6.98 (2H, m), 5.44-5.40 (2H, m), 1.39 (12H, s) 
HRMS (ESI) calcd for C26H22Br2N2O2 [M]+ 553.0048, found 553.0159 
4.1.1.3. 5-bromine-2-[[3-[(1,3-dihydro-3,3-dimethyl-1-ethyl-2H-indol-2-ylidene)methyl]-2-
hydroxy-4-oxo-2-cyclobuten-1-ylidene]methyl]- 5-bromine-3,3-trimethyl-1- ethyl-3H-indolium (Br-
C2) [15]. 
5-bromine-2,3,3-trimethyl-1-ethyl-3H-indolium iodide salt (3a-C2) (394.1 mg) and squaric acid 
(57.0 mg) in butanol/toluene solution (1:1, 2 ml) at 160° C for 30 min gave 250 mg of Br-C2, 0.41 
mmol, 82% yield. 
1H NMR (CDCl3) δ: 7.45 (2H, s), 7.43 (2H, d, J = 8 Hz), 6.86 (2H, d J = 8 Hz), 5.96 (2H, s), 
4.05(4H, m), 1.77 (12H, s), 1.38 (6H, t, J = 7 Hz) 
HRMS (ESI) calcd for C30H30Br2N2O2 [M]+ 609.0674, found 609.0824 
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4.1.1.4. 5-bromine-2-[[3-[(1,3-dihydro-3,3-dimethyl-1-butyl-2H-indol-2-ylidene)methyl]-2-
hydroxy-4-oxo-2-cyclobuten-1-ylidene]methyl]- 5-bromine-3,3-trimethyl-1- butyl-3H-indolium (Br-
C4) [15]. 
5-bromine-2,3,3-trimethyl-1-butyl-3H-indolium iodide salt (3a-C4) (422.1 mg) and squaric acid 
(57.0 mg) in butanol/toluene solution (1:1, 2 ml) at 160° C for 45 min gave 230 mg of Br-C4, 0.35 
mmol, 69% yield. 
1H NMR (CDCl3) δ: 7.45 (2H, s), 7.43 (2H, d, J = 8 Hz), 6.85 (2H, d J = 8 Hz), 5.99 (2H, s), 3.97 
(4H, bt), 1.77 (12H, s), 1.69 (4H, m), 1.52 (4H, m), 0.98 (6H, t, J = 7 Hz) 
HRMS (ESI) calcd for C34H38Br2N2O2 [M]+ 665.1300, found 665.1448 
4.1.1.5. 5-iodine-2-[[3-[(1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene)methyl]-2-hydroxy-4-oxo-2-
cyclobuten-1-ylidene]methyl]-5-iodine-3,3-trimethyl-3H-indole (I-NH). 
5-iodine-2,3,3-trimethyl-3H-indole (3b) (285.1 mg) and squaric acid (57.0 mg) in butanol/toluene 
solution (1:1, 2 ml) at 160° C for 30 min gave 181 mg of I-NH, 0.28 mmol, 56 % yield. 
1H NMR (DMSO-d6) δ: 7.87 (2H, s), 7.62 (2H, d, J = 8 Hz), 7.09 (2H, d J = 8 Hz), 5.58 (2H, s), 
1.43 (12H, s) 
HRMS (ESI) calcd for C26H22I2N2O2 [M]+ 647.9771, found 647.9836 
4.1.1.6. 5-iodine-2-[[3-[(1,3-dihydro-3,3-dimethyl-1-ethyl-2H-indol-2-ylidene)methyl]-2-hydroxy-
4-oxo-2-cyclobuten-1-ylidene]methyl]- 5-iodine-3,3-trimethyl-1- ethyl-3H-indolium (I-C2) 
5-iodine-2,3,3-trimethyl-1-ethyl-3H-indolium iodide salt (3b-C2) (441.1 mg) and squaric acid (57.0 
mg) in butanol/toluene solution (1:1, 2 ml) at 160° C for 30 min gave 176 mg of I-C2, 0.25 mmol, 
49% yield. 
1H NMR (DMSO-d6) δ: 7.90 (2H, s), 7.68 (2H, d, J = 8 Hz), 7.18 (2H, d J = 8 Hz), 5.77 (2H, s), 
4.09 (broad, 4H, m), 1.66 (12H, s), 1.25 (6H, t, J = 7 Hz) 
HRMS (ESI) calcd for C30H30I2N2O2 [M]+ 705.0397, found 705.0545 
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4.1.1.7. 5-iodine-2-[[3-[(1,3-dihydro-3,3-dimethyl-1-butyl-2H-indol-2-ylidene)methyl]-2-hydroxy-
4-oxo-2-cyclobuten-1-ylidene]methyl]- 5-butine-3,3-trimethyl-1- butyl-3H-indolium (I-C4). 
5-iodine-2,3,3-trimethyl-1-butyl-3H-indolium iodide salt (3b-C4) (469.1 mg) and squaric acid (57.0 
mg) in butanol/toluene solution (1:1, 2 ml) at 160° C for 45 min gave 208 mg of I-C4, 0.29 mmol, 
59% yield. 
1H NMR (DMSO-d6) δ: 7.91 (2H, s), 7.68 (2H, d, J = 8 Hz), 7.19 (2H, d J = 8 Hz), 5.79 (2H, s), 
4.05 (4H, m), 1.66 (12H, s), 1.53 (4H, m), 1.39 (4H, m), 0.93 (6H, t) 
HRMS (ESI) calcd for C34H38I2N2O2 [M]+ 761.1023, found 761.1176 
 
4.1.2. Evaluation of singlet oxygen generation ability 
 Solutions of DPBF (20µM) and dyes (5 µM) were prepared in phosphate buffer (2 mM, pH 
7.4) with 1% of DMSO. Each solution was placed in a 1 cm quartz cell and irradiated in an aerated 
solar box with a 250W lamp at various time intervals. Light was filtered in an optical filter with a 
515 nm cut-off. 
 
4.1.3. Biological assays 
4.1.3.1. Cell line and culturing 
 The HT-1080 human fibrosarcoma cell line (ATCC, Rockville, MD, USA) was cultured in 
Minimum Essential Medium Eagle (EMEM) supplemented with 2 mM L-glutamine, 100 UI/mL 
penicillin, 100 µg/mL streptomycin and 10% fetal bovine serum (Sigma Aldrich, St Louis, MO, 
USA). Cell lines were kept in a humidified atmosphere of 5% CO2 air at 37°C. 
 The effect that squaraine dyes (SQ-NH, Br-NH, I-NH, Br-C2, I-C2, Br-C4 and I-C4) had on 
HT-1080 cell growth was evaluated using a WST-1 cell proliferation assay (Roche Applied 
Science, Penzberg, Germany). Squaraine dyes were diluted in 100% dimethyl sulfoxide (DMSO, 
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Sigma Aldrich) at a final concentration of 2 mM. The obtained solutions were then briefly vortexed 
and aliquots were stored in tightly sealed dark vials at -20°C. 1 × 103 HT-1080 cells were seeded in 
100 µL of growth medium in replicates (n = 8) in a 96-well culture plate (TPP, Trasadingen, 
Switzerland). After 24 h of cell growth, the medium was removed and the cells incubated with in 
experimental media of differing squaraine concentrations (0.25, 0.50, 1.00 and 10 µM). The WST-1 
reagent (Roche	  Applied Science) (10 µL/100 µL) was added, at 24, 48 and 72 h, and plates were 
incubated at 37°C in 5% CO2 for 90 min. Well absorbance was measured at 450 and 620 nm 
(reference wavelength) in the microplate reader Asys UV340 (Biochrom, Cambridge, UK). Cell 
proliferation data were expressed as the ratio between the absorbance of treated and untreated cells. 
 
4.1.3.2. In vitro photodynamic treatment 
 The HT-1080 in the exponential phase were preincubated in the dark for 24 h in a culture 
medium containing squaraine derivatives at 1 µM, i.e. the maximum non-cytotoxic concentration 
tested. Cells were removed from the flask after incubation using a 0.05% trypsin-0.02% EDTA 
solution (Sigma Aldrich) and normalized to 1.5 × 105 cells in 1 mL of phosphate buffered solution 
(PBS, Sigma Aldrich) in polystyrene tubes (TPP). The light emitting source of the system is based 
on a light beam (LB), specifically a red LED with a wavelength of 636 nm and energy fluency rates 
adjusted to 15 mW/cm2. In particular, cellular suspensions were illuminated for 20 min in a dark 
box. After PDT, 1.5 x 103 cells were plated in a 96-well culture plate (TPP).  Cellular proliferation 
was evaluated at 24, 48 and 72 h using the WST-1 (Roche	   Applied Science) cell proliferation 
reagent (10 µL/100 µL). Cell proliferation data are expressed as the ratio between the absorbance of 
treated and untreated cells. 
 
4.1.3.3. Flow cytometric analysis 
 Squaraine dye cellular uptake analysis was carried out on C6 flow cytometry equipment 
(Accuri Cytometers, Milano, Italy). Briefly, 6 x 104 cells were plated in 6-well culture plates (TPP) 
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and incubated with squaraine dyes (1 µM) for 3, 6 and 24 h. Cells were detached after each 
incubation period using a 0.05% trypsin-0.02% EDTA solution (Sigma Aldrich) and re-suspended 
in 300 µL PBS (Sigma Aldrich). They were then run on the C6 flow cytometer (Accuri 
Cytometers), which considered 10,000 events, using 640 nm excitation to measure the intracellular 
squaraines. Intracellular fluorescence is expressed as integrated median fluorescence intensity 
(iMFI). This is the product of the frequency of cells that are positive to squaraine dye and the 
median fluorescence intensity of the cells. The most suitable squaraine concentration for the study 
was chosen according to iMFi ratio. Results are expressed in iMFI ratio, i.e., the ratio between the 
iMFI of treated and untreated cells. 
Reactive oxygen species (ROS) production was performed 1, 5, 15, 30, 45, 60 min after 
PDT. Cells were incubated with 10 µM of 2’,7’-dichlorofluorescein diacetate (DCFH-DA) (Sigma 
Aldrich) for 30 min, 24 h after incubation with squaraine dyes (Br-C4 or I-C4, 1 µM). After 
incubation, cells were washed with PBS, trypsinzed and 1.5 x 105 cells were collected in 1 ml of 
PBS and treated with a 15 mW/cm2 LB for 20 min. Cells were analyzed after treatment by a C6 
flow cytometer (Accuri Cytometers), which evaluated 10,000 events. ROS production was 
performed and the iMFI, which is the product of the frequency of ROS-producing cells and the 
median fluorescence intensity of the cells, was evaluated.  
Cell death was evaluated using the Dead Cell Apoptosis Kit with Annexin V-Alexa Fluor® 
488 and Propidium Iodide (PI) (Life Technologies, Milano, Italy).  Briefly, 2.0 x105 HT-1080 cells 
were incubated for 24 h with Br-C4 or I-C4 (1 µM), and then treated with LB at 15 mW/cm2 for 20 
min. Six hours after treatment, cells were detached with trypsin and washed with PBS (Sigma 
Aldrich), centrifuged at 375 rcf for 5 min and then re-suspended in 1x annexin-binding buffer and 
stained with Annexin V Alexa Fluor and PI. Samples were run on a C6 flow cytometer (Accuri 
Cytometers) at 488 nm excitation to measure Annexin V-Alexa Fluor® and at 530 nm to measure 
PI. 10,000 events were considered for the analysis and any cell debris with low forward scatter 
(FSC) and side scatter (SSC) were excluded. The two different stainings allowed us to distinguish 
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the apoptotic (Annexin V-Alexa Fluor® positive) and necrotic cells (Annexin V-Alexa Fluor® and 
PI positive) from viable cells (Annexin V-Alexa Fluor® and PI negative). All analyses were 
performed on a FCS Express 4 (BD Bioscience, Milano, Italy). 
DNA damage was evaluated 30 min after PDT treatment using a DNA Damage - AP site - 
Assay kit (Cell Based) (Abcam Company, Burlingame, California), and according to 
manufacturer’s instructions. In particular, an aldehyde reactive probe (ARP), that reacts specifically 
with the aldehyde groups that are formed by protein or DNA modification, was used to assess 
oxidative DNA damage. Aldehyde sites on both proteins and DNA were converted to biotin-tagged 
aldehyde sites, using an excess of ARP, and detected using avidin-conjugated reporters. Briefly, 5 × 
105 cells were incubated with Br-C4 or I-C4 1 µM for 24 h and then treated with PDT. The samples 
were run on a C6 flow cytometer at 488 nm to measure the avidin signal. Any cell debris with low 
FSC and SSC were excluded from the analyses and a total of 10000 events were analyzed. 
 Cytochrome c was analyzed 0.5 and 3 h after PDT treatment. Briefly, 5 × 105 cells were 
incubated with 1 µM Br-C4 or I-C4 for 24 h and then treated with PDT.  Cytosolic cytochrome c 
content was then ascertained in supernatants from the selectively permeabilized cells using an 
enzyme-linked immunosorbent assay (eBioscience, San Diego, CA, USA), according to 
manufacturer’s instructions. The concentration of cytochrome c (ng/mg) was then calibrated from a 
standard curve based on reference standards. 
 
4.1.4. Confocal analysis of squaraine dyes 
 In order to understand whether squaraine dyes colocalize with cell mitochondria, 
MitoTracker Green (Life Technologies), a mitochondria-specific probe, was used. Briefly, 1.0 x 104 
cells were left to attach for 48 h on glass coverslips in a 24-well plate (TPP) and then incubated 
with growth medium with squaraine dyes, Br-C4 or I-C4 1 µM, for 24 h. After incubation, the cells 
were washed and then incubated with MitoTracker Green (100 nM) for 45 min. Prior to 
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visualization, excess probe was washed off via rinsing four times in PBS and cells were fixed in 
paraformaldehyde. Coverslips were then mounted onto a glass slide and observed using an Olympus 
Fluoview 200 laser scanning confocal system (Olympus America Inc., Melville, NY, USA) 
mounted on an inverted IX70 Olympus microscope, equipped with 60X Uplan Fl (NA 1.25) and 
100X Uplan Fl (NA 1.30) oil-immersion objectives. MitoTracker Green was excited with a Ar/Kr 
laser at 488 nm and squaraine dyes by at 568 in order to simultaneously detect the probes. Images 
acquired at 60x magnification were processed and analysed with ImageJ software (Rasband,W.S., 
U.S. National Institutes of Health, Bethesda, MA). 
 
4.1.5. Real-time polymerase chain reaction (RT-PCR) 
 In order to evaluate the effect of PDT on mRNA gene expression, total RNA was isolated 
from HT-1080 at 0.5, 3 h and 24 h after photodynamic treatment. Briefly, 2.0 x 105 cells were 
collected in a RNA Cell Protection Reagent (Qiagen, Milano, Italy) and stored at -80 °C. Total 
RNA was obtained using the RNeasy Plus Mini kit (Qiagen) and total RNA concentration (µg/mL) 
was determined using a Qubit fluorometer (Life Technologies) and the Quant-IT RNA Assay Kit 
(Invitrogen, Milano, Italy). Calibration was performed using a two-point standard curve, according 
to manufacturer’s instructions. 
 Real-time RT-PCR analysis was carried out using 150 ng of total RNA that was reverse 
transcribed in 20 µL cDNA reaction volume using the QuantiTect Reverse Transcription Kit 
(Qiagen). In accordance with manufacturer's instructions, 12.5 ng of cDNA was used for each 10 
µL real time RT-PCR reaction. Quantitative RT-PCR was performed using a SsoFast EvaGreen 
(Bio-Rad, Milano, Italy) and after the QuantiTect Primer Assay (Qiagen), APAF1 (Cat No 
QT00092358), BAX (Cat No QT00062090), BCL2 (Cat No  QT00031192), GPX1 (Cat No 
QT00203392), NQO1(	   Cat No QT00050281), RRN18S (Cat No QT00199367), SOD2 (Cat No 
QT1008693), TP53 (Cat No QT00060235) were used. The transcript of the reference 18S ribosomal 
RNA (RRN18S) was used to normalize mRNA data and real-time PCR was performed using a 
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MiniOpticon Real Time PCR system (Bio-Rad). The PCR protocol conditions were as follows: 
HotStarTaq DNA polymerase activation step at 95°C for 30 seconds, followed by 40 cycles at 95°C 
for 5 seconds and 55°C for 10 seconds. All runs were performed on at least three independent 
cDNA preparations per sample and all samples were run in duplicate. At least two non-template 
controls were included in all PCR runs. Quantification data analyses were performed using Bio-Rad 
CFX Manager Software version 3.1 (Bio-Rad), according to manufacturer’s instruction. These 
analyses were performed in compliance with MIQE guidelines (Minimum Information for 
Publication of Quantitative Real-time PCR Experiment). 
4.1.6. Statistical analysis 
 Data are shown as average values of three independent experiments ± standard deviation. 
Statistical analyses were performed using Graph-Pad Prism 5.0 software (La Jolla, CA, USA); one-
way and two-way analyses of variance and Bonferroni’s test were used to calculate the threshold of 
significance. Statistical significance was set at p < 0.05. 
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Scheme 1. Structures of the synthesized compounds. 	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Scheme 2. Synthesis and quaternization of indolenines. 
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Scheme 3. Synthesis of squaraines. 
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Figure 1. Comparative synthesized squaraine 1O2 generation with methylene blue as standard 
reference. 
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Figure 2. Effects of squaraine dyes on HT-1080 cell proliferation. Cell proliferation, after exposure 
to increasing concentrations of squaraine dyes (0.25, 0.50, 1, 2, 10 µM), was evaluated at 24, 48 and 
72 h by WST-1 assay. Statistical significance versus untreated cells: * p < 0.05, ** p < 0.01, *** p 
< 0.001. 
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Figure 3. Squaraine cytofluorimetric cellular uptake. HT-1080 cells were incubated with squaraine 
dyes at the same concentration (1µM) for 3, 6 and 24 h. Fluorescent signal was detected using a 
flow cytometer at 540 nm excitation to measure the intracellular squaraine and expressed as the 
integrated median fluorescence intensity (iMFI) ratio calculated as reported in Materials and 
Methods. Statistical significance versus untreated cells: * p < 0.05, ** p < 0.01, *** p < 0.001 
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Figure 4. Effect of photodynamic treatment on HT-1080 proliferation as a function of time. Cells 
were incubated for 24 h with different squaraine dyes at the same concentration (1 µM) and then 
exposed to PDT with a light beam (LB) at 15 mW/cm2 for 20 min. Cell proliferation was evaluated 
after 24, 48 and 72 h by WST-1 assay. Statistically significant difference versus untreated cells: ** 
p < 0.01, *** p < 0.001. 
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Figure 5. Squaraine dyes colocalize with cell mitochondria. Representative confocal fluorescence 
images of HT-1080 cells incubated with either Br-C4 or I-C4 (red signal) at the same concentration 
(1µM) for 24 h and MitoTracker Green (green signal) (100 nM). A-D, MitoTracker Green; B-E, Br-
C4 and I-C4, respectively; C, merged imagine of panels A and B; F, merged imagine of panels D 
and E. Fluorescent signal was detected by a confocal microscopy with 488 and 568 nm excitation,	  
at 60x magnification. 
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Figure 6. HT-1080 reactive oxygen species (ROS) production after PDT as a function of time. HT-
1080 cells were exposed to PDT with a light beam (LB) at15 mW/cm2 for 20 min, alone or after cell 
incubation for 24 h with Br-C4 or I-C4 at the same concentration (1 µM). ROS levels were 
determined according to the dichlorofluorescin-diacetate assay by flow cytometry and expressed as 
the integrated average fluorescence ratio (iMFI) ratio, as described in Materials and Methods. 
Statistically significant difference versus untreated cells: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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Figure 7. Effects of photodynamic treatment with squaraine dyes on cell death, cytochrome c 
release and DNA damage. HT-1080 cells were exposed to PDT with a light beam (LB) at 15 
mW/cm2 for 20 min alone or after cell incubation for 24 h with Br-C4 or I-C4 squaraine dyes at the 
same concentration (1 µM). Panel A: Percentages of apoptotic and necrotic cells were obtained 6 h 
after treatment by flow cytometry with Annexin V-Alexa Fluor® 488 and Propidium Iodide (PI). 
Panel B: Cytochrome c was evaluated 0.5 and 3 h after PDT. Panel C: PDT induced damage in 
DNA was evaluated 30 min after treatment and the effect was compared to untreated cells, which 
are stated as 1 and shown by the dotted line. 
Statistical significance versus untreated cells: * p < 0.05, *** p < 0.001  
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Figure 8. mRNA expression analysis in HT-1080 cells, 0.5, 3 and 24 h after PDT. Cells were 
incubated for 24 h with either Br-C4 or I-C4 at the same concentration (1 µM) and then exposed to 
PDT with a light beam (LB) at 15 mW/cm2 for 20 min. RRN18S (ribosomal RNA 18S) was used as 
a reference gene to normalize the data. The photodynamic therapy-induced alterations in mRNA 
levels were compared with those of the untreated cells which are stated as 1 and shown by the 
dotted line. Panel A: mRNA expression of genes involved in the apoptotic pathway; Panel B: 
mRNA expression of genes involved in the oxidative damage pathway. Statistically significant 
difference versus untreated cells: * p < 0.05, ** p < 0.01, *** p < 0.001. 
 
